by Brian G. Filler, Robert M. Cattaneo on July 14, 2026
On July 13, 2026, the Federal Trade Commission (FTC) announced that it had secured a combined $12 million civil penalty settlement with Edwards Lifesciences Corporation and Genesis MedTech Group Limited to resolve allegations that the parties violated the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) in connection with Edwards’ acquisition of JC Medical, a Genesis subsidiary. This settlement represents the largest combined penalty ever imposed for failure to make an HSR filing and sends a clear message to
Go